Devices, systems and methods for repairing lumenal systems

Information

  • Patent Grant
  • 10398551
  • Patent Number
    10,398,551
  • Date Filed
    Monday, January 23, 2017
    8 years ago
  • Date Issued
    Tuesday, September 3, 2019
    5 years ago
Abstract
The disclosure provides systems and related methods for delivering a prosthesis to a target location. The system includes a tether delivery catheter and a prosthesis delivery catheter, and also can include a lock delivery catheter or knot pusher, as desired. Various embodiments of useful valve prostheses are also disclosed.
Description
BACKGROUND

Heart valves permit unidirectional flow of blood through the cardiac chambers to permit the heart to function as a pump. Valvular stenosis is one form of valvular heart disease that prevents blood from flowing through a heart valve, ultimately causing clinically significant heart failure in humans. Another form of valvular disease results from heart valves becoming incompetent. Failure of adequate heart valve closure permits blood to leak through the valve in the opposite direction to normal flow. Such reversal of flow through incompetent heart valves can cause heart failure in humans.


The human mitral valve is a complicated structure affected by a number of pathological processes that ultimately result in valvular incompetence and heart failure in humans. Components of the mitral valve include the left ventricle, left atrium, anterior and posterior papillary muscles, mitral annulus, anterior mitral leaflet, posterior mitral leaflet and numerous chordae tendonae. The anterior leaflet occupies roughly ⅔ of the mitral valve area whereas the smaller posterior leaflet occupies ⅓ of the area. The anterior mitral leaflet, however, hangs from the anterior ⅓ of the perimeter of the mitral annulus whereas the posterior mitral leaflet occupies ⅔ of the annulus circumference. Furthermore, the posterior mitral leaflet is often anatomically composed of three separate segments. In diastole, the anterior leaflet and the three posterior leaflets are pushed into the left ventricle opening. In systole, the leaflets are pushed toward the plane of the mitral annulus where the posterior leaflets and larger anterior leaflet come into coaptation to prevent blood flow from the left ventricle to the left atrium. The leaflets are held in this closed position by the chordae tendonae. Dysfunction or failure of one or more of these mitral components may cause significant mitral valvular regurgitation and clinical disease in humans.


Surgical treatment has been the gold standard since its introduction in the 1950s. Currently, there are two surgical options offered for treatment. The first, mitral valve replacement, requires complex surgery using cardiopulmonary bypass to replace the mitral valve using a mechanical or bioprosthetic valvular prosthesis. Although a time-tested and proven strategy for treatment, bioprostheic valves suffer from poor long-term durability and mechanical valves require anticoagulation. As an alternative, surgical mitral valve repair has emerged as a superior procedure to achieve mitral valve competence and normal function. This operation is really a collection of surgical techniques and prostheses that collectively are referred to a mitral valve repair. Each component of the mitral valve can be altered, replaced, repositioned, resected or reinforced to achieve mitral valve competence.


Mitral annuloplasty has become a standard component of surgical mitral valve repair. In performing this procedure, the circumference of the mitral valve annulus is reduced and/or reshaped by sewing or fixing a prosthetic ring or partial ring to the native mitral valve annulus. As a consequence of mitral annuloplasty, the posterior mitral leaflet often becomes fixed in a closed position, pinned against the posterior left ventricular endocardium. The opening and closure of the mitral valve is subsequently based almost entirely on the opening and closing of the anterior mitral valve leaflet.


SUMMARY

The purpose and advantages of the present disclosure will be set forth in and become apparent from the description that follows. Additional advantages of the disclosed embodiments will be realized and attained by the methods and systems particularly pointed out in the written description hereof, as well as from the appended drawings.


To achieve these and other advantages and in accordance with the purpose of the disclosure, as embodied herein, in one aspect, the disclosure includes a tether delivery catheter for delivering an anchored tether to an anatomical location. The tether delivery catheter includes an elongate torqueable drive shaft having a proximal end that can have a first handle attached thereto and a distal end having a coupling for receiving an anchor. The tether delivery catheter further includes an anchor received in a torqueable relationship with the coupling of the distal end of the elongate torqueable drive shaft. The anchor has an anchoring portion to be advanced into an anatomical location, and at least one elongate tether extending proximally from the anchor toward the first handle. The tether delivery catheter further includes an outer tubular member having a proximal end, a distal end and an elongate body surrounding the elongate torqueable drive shaft. The outer tubular member can include a handle near or at its proximal end. The second handle is preferably rotatable with respect to the first handle about a central axis of the catheter to permit the anchor and elongate torqueable drive shaft to be rotated with respect to the outer tubular member.


If desired, the anchor can include a single tether, or a plurality of tethers, such as two tethers. When a plurality of tethers is provided, a loading needle can be provided that is disposed on a proximal end of the tethers to facilitate routing the tethers through the tether delivery catheter prior to use. The anchoring portion of the anchor can include a helical thread, for example, among other suitable retaining structures. The anchoring portion can be anchored into tissue by rotating the first handle with respect to the second handle while urging the anchor against the tissue. When a helical anchoring portion is provided, this relative rotation can effectuate implantation of the anchoring portion.


In further accordance with the disclosure, a prosthesis delivery catheter or system and a prosthesis are also provided. In an exemplary embodiment, this catheter/system can include an elongate inner body having a proximal portion and a distal tip. The distal tip includes a first proximally extending tubular member having a freely floating proximal end. The first proximally extending tubular member and elongate inner body cooperate to define a first substantially annular chamber. The catheter/system further includes an elongate tubular outer body having a proximal portion and a distal end. The elongate tubular outer body can be disposed about a proximal region of the elongate inner body.


The elongate tubular outer body can be axially displaceable with respect to the elongate inner body. The distal end of the elongate tubular outer body can be configured to substantially abut the proximal end of the first proximally extending tubular member. A distal region of the elongate tubular outer body and the proximal region of the elongate inner body can cooperate to define a second substantially annular chamber. The first and second chambers can cooperate to define a prosthesis chamber for receiving a compressed prosthesis.


The catheter/system can further be provided with a preloaded compressed prosthesis disposed about the elongate inner body in the prosthesis chamber. The compressed prosthesis can have at least one rail eyelet for receiving a flexible rail. The at least one rail eyelet can extend radially outwardly through a juncture defined between the distal end of the elongate tubular outer body and the proximal end of the first proximally extending tubular member. The compressed prosthesis can be configured to expand radially outwardly when the elongate inner body is advanced distally with respect to the elongate tubular outer body. The elongate inner body and tubular outer body can be withdrawn proximally through a lumen defined by the prosthesis after deployment of the prosthesis without needing to disturb the prosthesis or anything in physical contact with the prosthesis.


In some implementations, the catheter/system can further include a radiopaque marker mounted on the system proximate the prosthesis chamber, such as on the first proximally extending tubular member overlapping a central region of the prosthesis chamber. If desired, the compressed prosthesis can include a plurality of rail eyelets, wherein each rail eyelet is configured to receive a flexible rail. In some implementations, the compressed prosthesis can include two rail eyelets, wherein each rail eyelet is configured to receive a flexible rail.


In various implementations, the compressed prosthesis includes a generally tubular body adapted for placement proximate a mitral annulus. The tubular body can have a generally tubular upper portion adapted to substantially reside in the left atrium above the mitral annulus. The generally tubular upper portion can have a first circumferential wall that is outwardly biased to urge against cardiac tissue of the left atrium. The first circumferential wall can include a plurality of independently articulable frame portions configured to grip around the circumference of the atrial side of the mitral annulus. The prosthesis can also include a generally tubular lower portion extending downwardly from the generally tubular upper portion. The generally tubular lower portion is preferably configured to substantially reside in the left ventricle below the mitral annulus. The lower portion can be defined by an generally circumferential wall that extends downwardly from the generally tubular upper portion. The generally tubular lower portion can include at least one independently articulable anchor biased to extend radially outwardly from the generally tubular lower portion to urge against the ventricular side of the mitral annulus to prevent the prosthesis from moving through the mitral opening toward the atrium. The prosthesis can also include at least one prosthetic valve leaflet disposed within the tubular body, the at least one prosthetic valve leaflet being configured to occupy at least a portion of an opening defined by the generally tubular upper portion and the lower portion.


In some implementations, the prosthesis can include a plurality of independently articulable anchors biased to extend radially outwardly from the generally tubular lower portion to urge against the ventricular side of the mitral annulus to prevent the prosthesis from moving through the mitral opening toward the atrium. If desired, the prosthesis can include a fabric spanning across a framework of the prosthesis.


In other implementations, the compressed prosthesis can include a generally tubular body adapted for placement proximate a mitral annulus. The tubular body can have a generally tubular upper portion adapted to substantially reside in the left atrium above the mitral annulus. The generally tubular upper portion can have a first circumferential wall that is outwardly biased to urge against cardiac tissue of the left atrium. The first circumferential wall can include a plurality of independently articulable frame portions configured to grip around the circumference of the atrial side of the mitral annulus. The prosthesis can also include a generally tubular lower portion extending downwardly from the generally tubular upper portion. The generally tubular lower portion can be configured to substantially reside in the left ventricle below the mitral annulus. The lower portion can be defined by an generally circumferential wall that extends downwardly from the generally tubular upper portion. The generally tubular lower portion can include at least one downwardly extending pole for permitting attachment of a tissue valve. The prosthesis can similarly include at least one prosthetic valve leaflet disposed within the tubular body. The at least one prosthetic valve leaflet can be configured to occupy at least a portion of an opening defined by the generally tubular upper portion and the lower portion.


In further implementations, the compressed prosthesis can include a generally tubular body adapted for placement proximate a mitral annulus. The tubular body can have a generally tubular upper portion adapted to substantially reside in the left atrium above the mitral annulus. The generally tubular upper portion can have a first circumferential wall having a first circumferential end and a second circumferential end, and defining a first circumferential gap therebetween. The generally tubular upper portion can be biased to urge against cardiac tissue of the left atrium. The first circumferential wall can include a plurality of independently articulable frame portions configured to grip around the circumference of the atrial side of the mitral annulus. The prosthesis can further include a generally tubular lower portion extending downwardly from the generally tubular upper portion. The generally tubular lower portion can be configured to substantially reside in the left ventricle below the mitral annulus. The lower portion can be defined by a generally circumferential wall that extends downwardly from the generally tubular upper portion and has a first circumferential end and a second circumferential end separated by a second circumferential gap therebetween. The prosthesis can further include at least one prosthetic valve leaflet disposed within the tubular body, the at least one prosthetic valve leaflet being configured to occupy at least a portion of an opening defined by the generally tubular upper portion and the lower portion.


In further implementations, the prosthesis can include an inflatable bladder disposed in the generally tubular lower portion of the prosthesis. The inflatable bladder can being configured to be inflatable so as to facilitate adjustment of the prosthesis, such as during installation.


The disclosure further provides a lock deployment catheter having a proximal end and a distal end for delivering a deployable lock over a tether to an anatomical location. The catheter includes an outer tubular member having a proximal end, a distal end and an elongate tubular body defining a lumen therethrough, and an inner elongate member disposed in the lumen of the outer tubular member. The inner elongate member can include a proximal end, a distal end and an elongate body. The catheter can further include a deployable lock disposed in a distal region of the lumen of the outer tubular member. The deployable lock can be configured to be pushed distally out of the outer tubular member by displacing the inner elongate member distally with respect to the outer tubular member. The catheter can also include an elongate removable snare having a proximal end and a distal end with a hook configured to capture a filament. The snare can be routed along a path through the distal end of the lock deployment catheter, the lock and at least a portion of the outer tubular member. The snare can be configured to capture a filament and pull the filament along the path and out of a proximal portion of the catheter.


If desired, the lock deployment catheter can further include an axial compressive limit spring for biasing the inner elongate member in a proximal direction with respect to the outer tubular member. The inner elongate member can include a first handle disposed at the proximal end thereof and the outer tubular member can include a second handle disposed at the proximal end thereof. The limit spring can be compressed and the lock can be released when the handles are pushed together along a longitudinal axis of the catheter.


If desired, the lock deployment catheter can further include a lock housing disposed in the distal region of the outer tubular member. The lock housing can be configured to selectively receive the deployable lock. The lock can include a body with a first bore defined therein that is parallel to the lumen of the outer tubular member for receiving the snare therethrough, and a second bore oriented obliquely with respect to the first bore for receiving a spring loaded retainer. The spring loaded retainer can be in a first compressed state when the deployable lock is disposed in the outer tubular member. The spring loaded retainer can expand out of the second bore when the lock is urged distally outwardly of the catheter.


In some implementations, the lock can urge against the snare prior to pulling the filament through the catheter. If desired, the path can pass through an orifice formed in the spring loaded retainer.


The disclosure also provides systems and related methods for delivering a prosthesis to a target location. The system includes a tether delivery catheter as described herein and a prosthesis delivery catheter as described herein. The system can also include a lock delivery catheter or knot pusher, as desired.


It is to be understood that both the foregoing general description and the following detailed description are exemplary and are intended to provide further explanation of the embodiments disclosed herein.


The accompanying drawings, which are incorporated in and constitute part of this specification, are included to illustrate and provide a further understanding of the method and system of the disclosure. Together with the description, the drawings serve to explain the principles of the disclosed embodiments.





BRIEF DESCRIPTION OF THE DRAWINGS

The foregoing and other objects, aspects, features, and advantages of exemplary embodiments will become more apparent and may be better understood by referring to the following description taken in conjunction with the accompanying drawings, in which:



FIG. 1 illustrates an exemplary placement of an active rail fixation anchor/screw for both partial and full mitral valve replacement from a sub-annulus view of mitral valve region.



FIG. 2(a) illustrates an exemplary articulating anchor and rail delivery system.



FIG. 2(b) illustrates an exemplary single rail tether and anchor.



FIG. 2(c) illustrates an exemplary double rail tether joined by a needle at a proximal end with an anchor, permitting the loading needle to be cut and the two ends of tethers for each anchor to be knotted and advanced to the surgical site to obviate the need for a lock.



FIG. 3(a) illustrates advancing an exemplary loaded prosthesis valve (full or partial replacement) delivery system over a rail or tether to the mitral region.



FIG. 3(b) illustrates a closer view of advancing an exemplary loaded prosthesis valve (full or partial replacement) delivery system over rails toward a mitral valve.



FIG. 3(c) illustrates advancement of an exemplary loaded prosthesis valve (full or partial replacement) delivery system over only rails anchored at location P2.



FIG. 3(d) illustrates advancing an exemplary loaded prosthesis valve (full or partial replacement) delivery system over rails to the mitral valve.



FIG. 3(e) illustrates deploying an exemplary prosthesis valve (full replacement) delivery system over active rails to the mitral valve.



FIG. 3(f) illustrates an exemplary deployed full prosthesis over guide rails, wherein the prosthesis is in place, ready to be locked in place with locks.



FIG. 3(g) illustrates deploying an exemplary prosthesis (partial replacement) delivery system over rails.



FIG. 3(h) illustrates an exemplary prosthesis with a tissue cover that coapts against a native anterior leaflet.



FIG. 3(i) illustrates an exemplary deployed partial prosthesis over guide rails, wherein the prosthesis is in place and ready to be secured.



FIGS. 4(a), 4(b) and 4(c) illustrate different views of an exemplary prosthesis delivery system with a prosthesis.



FIG. 5(a) illustrates an exemplary locking catheter.



FIG. 5(b) illustrates an exemplary lock for the locking catheter.



FIG. 6(a) illustrates an exemplary lock delivery system with lock and snare for threading a guide rail through the lock and delivery system.



FIG. 6(b) illustrates an exemplary lock released in place with the delivery catheter removed from a left ventricular (“LV”) view.



FIG. 6(c) illustrates an exemplary procedure completed using a partial mitral valve replacement prosthesis, LV view.



FIG. 6(d) illustrates an exemplary procedure using a full prosthesis, LV view.



FIGS. 7(a), 7(b) and 7(c) illustrate an exemplary full retrievable partially compliant prosthesis with a tissue cover (partial replacement) delivered with guide rails anchored a locations P1, P2 and P3.



FIGS. 8(a) and 8(b) illustrate an exemplary full replacement prosthesis with self expanding anchors.



FIG. 9 illustrates an exemplary guide rail based prosthesis delivery technique using a percutaneous approach that permits delivery and fixation of a prosthesis to the top of mitral annulus while preserving the native leaflets and sub-annulus anatomy.



FIG. 10 illustrates an exemplary guide rail based prosthesis delivery technique using an apical approach through the left ventricle.





DETAILED DESCRIPTION

Reference will now be made in detail to the present preferred embodiments of the disclosure, examples of which are illustrated in the accompanying drawings. The method and corresponding steps of the disclosed embodiments will be described in conjunction with the detailed description of the system.


Exemplary embodiments provide systems, devices and methods for repairing or replacing elements of the mitral valve, but it will be appreciated that similar approaches can be used to deliver other prostheses, such as lumenal stents, by providing the stent with at least one guide loop that extends outside of the delivery system so as to accept a guide rail. This can be particularly useful when delivering stents to lumenal locations that experience strong flow or pressure gradients and/or reversal in blood flow. Exemplary elements of the valve prosthesis include the device frame, prosthetic posterior mitral leaflet equivalent and elements to prevent or reduce abnormal prolapse of the native anterior mitral leaflet during systole. Exemplary methods of implanting the valve prosthesis include direct open surgical placement, minimally invasive surgical placement either with or without the use of cardiopulmonary bypass, and totally catheter based implantation. Exemplary methods for maintaining the valve prosthesis in the preferred mitral annular location include external compression, compression following rail or suture guided implantation and seating with subsequent active or passive fixation of the valve prosthesis based upon the rail or suture guides.



FIG. 1. illustrates placement of an active rail fixation anchor/screw for both partial and full mitral valve replacement from a sub-annulus view of mitral valve 300 region. Posterior sub-annulus and posterior leaflet fixation locations and numbers can vary depending on fixation requirements and prosthesis design. Should be from commissure to commissure along the posterior sub-annulus and posterior leaflet. Preferably P2 or P1 and P3.


Anchor Delivery Catheter


In accordance with a first aspect, the disclosure includes an anchor and tether delivery catheter for delivering an anchored tether to an anatomical location.


For purposes of illustration, and not limitation, as illustrated in FIGS. 2(a)-2(c), a tether delivery catheter 100 is provided that includes an elongate torqueable drive shaft 320 having a proximal end 102 that can have a first handle 322 attached thereto and a distal end 104 having a coupling or holding chamber 316 for receiving an anchor. The tether delivery catheter 100 further includes an anchor 312 received in a torqueable relationship with the coupling 316 of the distal end 104 of the elongate torqueable drive shaft 320. As shown in FIG. 2a, the anchor 312 has an anchoring portion to be advanced into an anatomical location, and at least one elongate tether 302 extending proximally from the anchor 312 toward the first handle 322. As shown in FIG. 2A, the tether delivery catheter 100 further includes an outer tubular member 318 having a proximal end, a distal end and an elongate body (not shown) surrounding the elongate torqueable drive shaft 320. The outer tubular member 318 can include a handle 106 near or at its proximal end, as illustrated. The second handle 106 is preferably rotatable with respect to the first handle about a central axis of the catheter to permit the anchor 312 and elongate torqueable drive shaft 320 to be rotated with respect to the outer tubular member 318.


If desired, the anchor 312 can include a single tether 302 as illustrated in FIG. 2(a), or a plurality of tethers 324, such as two tethers as illustrated in FIG. 2(c). When a plurality of tethers 324 is provided, a loading needle 326 can be provided that is disposed on a proximal end 328 of the tethers 302 to facilitate routing the tethers through the tether delivery catheter 100 prior to use. The anchoring portion of the anchor 312 can include a helical thread as illustrated, for example, among other suitable retaining structures. The anchoring portion can be anchored into tissue by rotating the first handle 322 with respect to the second handle 106 while urging the anchor 312 against the tissue. When a helical anchoring portion is provided, this relative rotation can effectuate implantation of the anchoring portion. This yields the arrangement in FIG. 1 wherein the anchors and tethers are attached to the mitral annulus 300. With these rails in place, a prosthesis can be threaded over the rail(s) and delivered to the mitral annulus. The tether(s) can include, in some implementations, a hollow braided suture material including a radiopaque core material inserted along its length such as a high density radiopaque fluoropolymer, radiopaque HDPE material, or other suitable radiopaque material.


Prosthesis Delivery Catheter


In further accordance with the disclosure as illustrated in FIGS. 3(a)-4(c), a prosthesis delivery catheter or system and a prosthesis are provided. As shown in FIGS. 3(a) and 4(b), in an exemplary embodiment, this catheter/system can include an elongate inner body 398 (FIG. 4b) having a proximal portion and a distal tip 358. The distal tip 358 includes a first proximally extending tubular member 393 having a freely floating proximal end. The first proximally extending tubular member 393 and elongate inner body 395 cooperate to define a first substantially annular chamber 392. The catheter/system further includes an elongate tubular outer body 320 having a proximal portion and a distal end. The elongate tubular outer body 320 can be disposed about a proximal region of the elongate inner body 395.


The elongate tubular outer body 320 can be axially displaceable with respect to the elongate inner body 395. The distal end of the elongate tubular outer body 320 can be configured to substantially abut the proximal end of the first proximally extending tubular member 393. A distal region of the elongate tubular outer body 320 and the proximal region of the elongate inner body 395 can cooperate to define a second substantially annular chamber 396. As shown in FIGS. 4(a) and 4(b) The first and second chambers 392, 396 can cooperate to define a prosthesis chamber 338 for receiving a compressed prosthesis 401.


As shown in FIG. 4(c), the catheter/system can further be provided with a preloaded compressed prosthesis 401 disposed about the elongate inner body 395 in the prosthesis chamber 338. The compressed prosthesis 401 can have at least one rail eyelet 336 for receiving a flexible rail. The at least one rail eyelet 336 can extend radially outwardly through a juncture defined between the distal end of the elongate tubular outer body and the proximal end of the first proximally extending tubular member. The compressed prosthesis 401 can be configured to expand radially outwardly when the elongate inner body 398 is advanced distally with respect to the elongate tubular outer body 320. The elongate inner body 398 and tubular outer body 320 can be withdrawn proximally through a lumen defined by the prosthesis after deployment of the prosthesis without needing to disturb the prosthesis or anything in physical contact with the prosthesis.


In some implementations, and as shown in FIG. 4(a) the catheter/system can further include a radiopaque marker 394 mounted on the system proximate the prosthesis chamber 338, such as on the first proximally extending tubular member 393 overlapping a central region of the prosthesis chamber 338. As shown in FIG. 4(c), if desired, the compressed prosthesis 401 can include a plurality of rail eyelets 336, wherein each rail eyelet 336 is configured to receive a flexible rail. In some implementations, the compressed prosthesis can include two rail eyelets 336, wherein each rail eyelet is configured to receive a flexible rail.


In various implementations as illustrated in the Figures, the compressed prosthesis 400 includes a generally tubular body 320 adapted for placement proximate a mitral annulus. As shown in FIG. 3(e), the tubular body 320 can have a generally tubular upper portion (e.g., 368) adapted to substantially reside in the left atrium above the mitral annulus 363. The generally tubular upper portion 368 can have a first circumferential wall 365 that is outwardly biased to urge against cardiac tissue 367 of the left atrium. The first circumferential wall 365 can include a plurality of independently articulable frame portions 369 configured to grip around the circumference of the atrial side of the mitral annulus 363. As shown in FIG. 3(c) and FIG. 3(f), the prosthesis can also include a generally tubular lower portion 371 extending downwardly from the generally tubular upper portion 368. The generally tubular lower portion 371 is preferably configured to substantially reside in the left ventricle below the mitral annulus 363. The tubular lower portion 371 can be defined by an generally circumferential wall that extends downwardly from the generally tubular upper portion 368. The generally tubular lower portion 371 can include at least one independently articulable anchor 348 biased to extend radially outwardly from the generally tubular lower portion 371 to urge against the ventricular side of the mitral annulus 363 to prevent the prosthesis from moving through the mitral opening toward the atrium. The prosthesis can also include at least one prosthetic valve leaflet disposed within the tubular body, the at least one prosthetic valve leaflet being configured to occupy at least a portion of an opening defined by the generally tubular upper portion and the lower portion.


In some implementations (all illustrated embodiments and in FIG. 8(a)), the prosthesis can include a plurality of independently articulable anchors 454 biased to extend radially outwardly from the generally tubular lower portion to urge against the ventricular side of the mitral annulus to prevent the prosthesis from moving through the mitral opening toward the atrium. As shown in FIG. 3(g) and FIG. 3(h), if desired, the prosthesis can include a fabric 378 spanning across a framework of the prosthesis.


In other implementations (e.g., FIG. 8(b), 3(c), 3(f)), the compressed prosthesis 401 can include a generally tubular body adapted for placement proximate a mitral annulus. The tubular body can have a generally tubular upper portion adapted to substantially reside in the left atrium above the mitral annulus. The generally tubular upper portion can have a first circumferential wall that is outwardly biased to urge against cardiac tissue of the left atrium. The first circumferential wall can include a plurality of independently articulable frame portions configured to grip around the circumference of the atrial side of the mitral annulus. The prosthesis can also include a generally tubular lower portion extending downwardly from the generally tubular upper portion. The generally tubular lower portion can be configured to substantially reside in the left ventricle below the mitral annulus. The lower portion can be defined by an generally circumferential wall that extends downwardly from the generally tubular upper portion. The generally tubular lower portion can include at least one downwardly extending pole 468 for permitting attachment of a tissue valve. The prosthesis can similarly include at least one prosthetic valve leaflet disposed within the tubular body. The at least one prosthetic valve leaflet can be configured to occupy at least a portion of an opening defined by the generally tubular upper portion and the lower portion.


Exemplary Prostheses


In further implementations (e.g., FIGS. 3(g)-3(i), 7(b). 7(c)), and as described above, the compressed prosthesis can include a generally tubular body adapted for placement proximate a mitral annulus. The tubular body can have a generally tubular upper portion adapted to substantially reside in the left atrium above the mitral annulus. The generally tubular upper portion can have a first circumferential wall having a first circumferential end and a second circumferential end, and defining a first circumferential gap therebetween. The generally tubular upper portion can be biased to urge against cardiac tissue of the left atrium. The first circumferential wall can include a plurality of independently articulable frame portions configured to grip around the circumference of the atrial side of the mitral annulus. The prosthesis can further include a generally tubular lower portion extending downwardly from the generally tubular upper portion. The generally tubular lower portion can be configured to substantially reside in the left ventricle below the mitral annulus. The lower portion can be defined by a generally circumferential wall that extends downwardly from the generally tubular upper portion and has a first circumferential end and a second circumferential end separated by a second circumferential gap therebetween. The prosthesis can further include at least one prosthetic valve leaflet 382 disposed within the tubular body, the at least one prosthetic valve leaflet being configured to occupy at least a portion of an opening defined by the generally tubular upper portion and the lower portion.


In further implementations (e.g., FIG. 7(a)), the prosthesis can include an inflatable bladder disposed in the generally tubular lower portion of the prosthesis. The inflatable bladder can being configured to be inflatable so as to facilitate adjustment of the prosthesis, such as during installation.


Lock Deployment Catheter


The disclosure further provides a lock deployment catheter (see FIGS. 5, 6) having a proximal end and a distal end for delivering a deployable lock 400 over a guide tether to an anatomical location. The catheter 500 (FIG. 5(a)) includes an outer tubular member 404 having a proximal end, a distal end and an elongate tubular body 405 defining a lumen therethrough, and an inner elongate member (not shown) disposed in the lumen of the outer tubular member 404. The inner elongate member can include a proximal end, a distal end and an elongate body. The catheter can further include a deployable lock 400 disposed in a distal region of the lumen of the outer tubular member 404. The deployable lock 400 can be configured to be pushed distally out of the outer tubular member 404 by displacing the inner elongate member distally with respect to the outer tubular member 404. In FIG. 6(a), the catheter 500 can also include an elongate removable snare 422 having a proximal end and a distal end with a hook configured to capture a filament. The snare 422 can be routed along a path through the distal end of the lock deployment catheter 500, the lock 400 and at least a portion of the outer tubular member 404. As illustrated in FIG. 6(a), the snare 422, and hence guide rail 402, can pass through the distal end of the lock heter along a proximal direction and outside of the catheter though a hole in the outer wall of the catheter. The snare can 422 be configured to capture a filament and pull the filament along the path and out of a proximal portion of the catheter.


As shown in FIG. 5(a), if desired, the lock deployment catheter 500 can further include an axial compressive limit spring 408 for biasing the inner elongate member in a proximal direction with respect to the outer tubular member 404. The inner elongate member can include a first handle 410 disposed at the proximal end thereof and the outer tubular member can include a second handle 406 disposed at the proximal end thereof. The limit spring can be compressed and the lock can be released when the handles are pushed together along a longitudinal axis of the catheter.


If desired, the lock deployment catheter can further include a lock housing 403 disposed in the distal region of the outer tubular member. The lock housing 403 can be configured to selectively receive the deployable lock 400. As illustrated in FIG. 5(b), the lock 400 can include a body 402 with a first bore defined therein that is parallel to the lumen of the outer tubular member 404 for receiving the snare 422 therethrough, and a second bore oriented obliquely with respect to the first bore for receiving a spring loaded retainer 412. The spring loaded retainer 412 can be in a first compressed state when the deployable lock 400 is disposed in the outer tubular member 404. The spring loaded retainer 412 can expand out of the second bore when the lock is urged distally outwardly of the catheter.


In some implementations, the lock can urge against the snare prior to pulling the filament through the catheter. If desired, the path can pass through an orifice 409 formed in the spring loaded retainer.


Systems, Kits and Delivery Methods


The disclosure also provides systems and related methods for delivering a prosthesis to a target location. The system includes a tether delivery catheter as described herein and a prosthesis delivery catheter as described herein. The system can also include a lock delivery catheter or knot pusher, as desired.



FIG. 9 illustrates a percutaneous approach using the devices illustrated herein. FIG. 10 describes an apical approach. The methods themselves are described in further detail in International Application No. PCT/US2011/59586, filed Nov. 7, 2011 which are incorporated by reference herein above.


All statements herein reciting principles, aspects, and embodiments of the invention, as well as specific examples thereof, are intended to encompass both structural and functional equivalents thereof. Additionally, it is intended that such equivalents include both currently known equivalents as well as equivalents developed in the future, i.e., any elements developed that perform the same function, regardless of structure.


The methods and systems of the present disclosure, as described above and shown in the drawings, provide for improved techniques for treating mitral valves of patients. It will be apparent to those skilled in the art that various modifications and variations can be made in the devices, methods and systems of the present disclosure without departing from the spirit or scope of the disclosure. Thus, it is intended that the present disclosure include modifications and variations that are within the scope of the subject disclosure and equivalents.

Claims
  • 1. A prosthesis delivery catheter, comprising: a) an elongate inner body having a distal tip;b) an elongate tubular outer body being disposed about the elongate inner body, the elongate tubular outer body being axially displaceable with respect to the elongate inner body, a distal region of the elongate tubular outer body and the elongate inner body cooperating to define a substantially annular prosthesis chamber for receiving a compressed prosthesis; andc) a compressed prosthesis disposed about the elongate inner body in the prosthesis chamber, the compressed prosthesis having at least one tether eyelet, the at least one tether eyelet being configured for receiving an elongate tether therethrough; andd) at least one elongate tether extending along an outside surface of the prosthesis delivery catheter, wherein the at least one tether extends along a first exterior portion of the prosthesis delivery catheter, through the at least one tether eyelet, and along a second exterior portion of the prosthesis delivery catheter, the compressed prosthesis being configured to expand radially outwardly and deployed when the elongate inner body is displaced axially with respect to the elongate tubular outer body to permit the prosthesis to be advanced along the at least one elongate tether toward an anchor that is anchored at an anatomical location where the prosthesis is to be installed.
  • 2. The prosthesis delivery catheter of claim 1, wherein the prosthesis includes a single tether eyelet and further wherein the at least one elongate tether is radiopaque.
  • 3. The prosthesis delivery catheter of claim 1, wherein the at least one tether eyelet includes a plurality of tether eyelets extending radially outwardly therefrom and radially outwardly past the outer surface of the elongate tubular outer body, the plurality of tether eyelets being circumferentially spaced from each other about a longitudinal axis of the prosthesis delivery catheter.
  • 4. The prosthesis delivery catheter of claim 3, wherein the plurality of tether eyelets are spaced equally from each other about the longitudinal axis of the prosthesis delivery catheter.
  • 5. The prosthesis delivery catheter of claim 3, wherein the at least one tether eyelet includes two tether eyelets spaced from each other about the longitudinal axis of the prosthesis delivery catheter.
  • 6. The prosthesis delivery catheter of claim 3, wherein two tether eyelets of the plurality of tether eyelets are spaced from each other by about 180 degrees.
  • 7. The prosthesis delivery catheter of claim 1, wherein at least one tether eyelet extends radially outwardly through a juncture defined in the tubular outer body.
  • 8. The prosthesis delivery catheter of claim 1, wherein the tubular outer body includes a radiopaque marker.
  • 9. The prosthesis delivery catheter of claim 1, wherein the prosthesis includes a generally tubular body configured for placement proximate a mitral annulus having a generally tubular upper portion configured to substantially reside in the left atrium above the mitral annulus, the generally tubular upper portion having a first circumferential wall that is outwardly biased to urge against cardiac tissue of the left atrium.
  • 10. The prosthesis delivery catheter of claim 9, wherein the first circumferential wall includes a plurality of independently articulable loops that are configured to grip around the circumference of the atrial side of the mitral annulus.
  • 11. The prosthesis delivery catheter of claim 10, wherein the prosthesis also includes a generally tubular lower portion extending downwardly from the generally tubular upper portion, the generally tubular lower portion being configured to substantially reside in the left ventricle below the mitral annulus, the tubular lower portion being defined by a generally circumferential wall that extends downwardly from the generally tubular upper portion.
  • 12. The prosthesis delivery catheter of claim 11, wherein the generally tubular lower portion includes at least one independently articulable anchor biased to extend radially outwardly from the generally tubular lower portion to urge against the ventricular side of the mitral annulus to prevent the prosthesis from moving through the mitral opening toward the atrium.
  • 13. The prosthesis delivery catheter of claim 12, further comprising at least one prosthetic valve leaflet disposed within the tubular body, the at least one prosthetic valve leaflet being configured to occupy at least a portion of an opening defined by the generally tubular upper portion and the lower portion.
  • 14. The prosthesis delivery catheter of claim 11, wherein the prosthesis includes a plurality of independently articulable anchors that are biased to extend radially outwardly from the generally tubular lower portion to urge against the ventricular side of the mitral annulus to prevent the prosthesis from moving through the mitral opening toward the atrium.
  • 15. The prosthesis delivery catheter of claim 11, wherein the generally tubular lower portion includes at least one downwardly extending pole for permitting attachment of a tissue valve thereto.
  • 16. The prosthesis delivery catheter of claim 10, wherein the prosthesis includes a fabric spanning across a framework of the prosthesis.
  • 17. The prosthesis delivery catheter of claim 10, wherein the plurality of independently articulable loops include a fabric material disposed on the loops.
  • 18. The prosthesis delivery catheter of claim 1, wherein the prosthesis includes a generally tubular upper portion having a first circumferential wall that in turn has a first circumferential end and a second circumferential end, and defining a first circumferential gap therebetween.
  • 19. The prosthesis delivery catheter of claim 18, wherein the generally tubular upper portion is biased to urge against cardiac tissue of the left atrium.
  • 20. The prosthesis delivery catheter of claim 19, wherein the first circumferential wall includes a plurality of independently articulable frame portions configured to grip around the circumference of the atrial side of the mitral annulus.
CROSS-REFERENCE TO RELATED APPLICATIONS

This patent application is a continuation-in-part of, and claims the benefit of priority to, U.S. patent application Ser. No. 14/074,517, filed Nov. 7, 2013, now U.S. Pat. No. 9,549,817, issued Jan 24, 2017, which in turn claims the benefit of priority to U.S. Provisional Patent Application Ser. No. 61/723,734, filed Nov. 7, 2012. This application is also related to U.S. patent application Ser. No. 13/240,793, filed Sep. 22, 2011, now abandoned, International Application No. PCT/US2013/28774, filed Mar. 2, 2013, and International Application No. PCT/US2011/59586, filed Nov. 7, 2011. The entire contents of each of the above referenced patent applications is incorporated herein by reference for any purpose whatsoever.

US Referenced Citations (142)
Number Name Date Kind
4106129 Carpentier et al. Aug 1978 A
4259753 Liotta et al. Apr 1981 A
4666442 Arru et al. May 1987 A
4692164 Dzemeshkevich et al. Sep 1987 A
5411552 Andersen et al. May 1995 A
5449384 Johnson Sep 1995 A
5606928 Religa et al. Mar 1997 A
5788715 Watson, Jr. et al. Aug 1998 A
5861028 Angell Jan 1999 A
5895410 Forber et al. Apr 1999 A
5928281 Huynh et al. Jul 1999 A
6059769 Lunn et al. May 2000 A
6106510 Lunn et al. Aug 2000 A
6375774 Lunn et al. Apr 2002 B1
6599303 Peterson Jul 2003 B1
6602271 Adams et al. Aug 2003 B2
6716231 Rafiee et al. Apr 2004 B1
6733525 Yang et al. May 2004 B2
6790229 Berreklouw Sep 2004 B1
6797000 Simpson et al. Sep 2004 B2
6800081 Parodi Oct 2004 B2
6866677 Douk et al. Mar 2005 B2
6911036 Douk et al. Jun 2005 B2
6953476 Shalev Oct 2005 B1
6960217 Bolduc Nov 2005 B2
7044958 Douk et al. May 2006 B2
7066946 Douk et al. Jun 2006 B2
7189259 Simionescu et al. Mar 2007 B2
7195641 Palmaz et al. Mar 2007 B2
7201772 Schwammenthal et al. Apr 2007 B2
7294135 Stephens et al. Nov 2007 B2
7316706 Bloom et al. Jan 2008 B2
7399315 Iobbi Jul 2008 B2
7425219 Quadri Sep 2008 B2
7442204 Schwammenthal et al. Oct 2008 B2
7442207 Rafiee Oct 2008 B2
7445631 Salahieh et al. Nov 2008 B2
7481838 Carpentier et al. Jan 2009 B2
7491232 Bolduc et al. Feb 2009 B2
7524330 Berreklouw Apr 2009 B2
7655040 Douk et al. Feb 2010 B2
7682352 Rafiee et al. Mar 2010 B2
7699892 Rafiee et al. Apr 2010 B2
7716801 Douk et al. May 2010 B2
7753840 Simionescu et al. Jul 2010 B2
7753949 Lamphere et al. Jul 2010 B2
7780726 Seguin Aug 2010 B2
7799069 Bailey et al. Sep 2010 B2
7806917 Xiao Oct 2010 B2
7806919 Bloom et al. Oct 2010 B2
7815673 Bloom et al. Oct 2010 B2
7947072 Yang et al. May 2011 B2
7955384 Rafiee et al. Jun 2011 B2
7972370 Douk et al. Jul 2011 B2
7998188 Zilla et al. Aug 2011 B2
8002825 Letac et al. Aug 2011 B2
8052750 Tuval et al. Nov 2011 B2
8062355 Figulla et al. Nov 2011 B2
8070802 Lamphere et al. Dec 2011 B2
8092518 Schreck Jan 2012 B2
8092520 Quadri Jan 2012 B2
8092524 Nugent et al. Jan 2012 B2
8226710 Nguyen et al. Jul 2012 B2
8252051 Chau et al. Aug 2012 B2
8308798 Pintor et al. Nov 2012 B2
8337541 Quadri et al. Dec 2012 B2
8348995 Tuval et al. Jan 2013 B2
8348996 Tuval et al. Jan 2013 B2
8353954 Cai et al. Jan 2013 B2
8353955 Styrc et al. Jan 2013 B2
20010021872 Bailey et al. Sep 2001 A1
20020032481 Gabbay Mar 2002 A1
20020138138 Yang Sep 2002 A1
20030055495 Pease et al. Mar 2003 A1
20030065386 Weadock Apr 2003 A1
20030097172 Shalev et al. May 2003 A1
20040087998 Lee et al. May 2004 A1
20040127916 Bolduc et al. Jul 2004 A1
20050038508 Gabbay Feb 2005 A1
20050043790 Seguin Feb 2005 A1
20050055082 Ben-Muvhar et al. Mar 2005 A1
20050137686 Salahieh Jun 2005 A1
20050137769 Salahieh et al. Jun 2005 A1
20050143809 Salahieh et al. Jun 2005 A1
20050177180 Kaganov et al. Aug 2005 A1
20050288706 Widomski et al. Dec 2005 A1
20060085012 Dolan Apr 2006 A1
20060106449 Ben-Muvhar May 2006 A1
20060106450 Ben-Muvhar May 2006 A1
20060173537 Yang et al. Aug 2006 A1
20070043435 Seguin et al. Feb 2007 A1
20070067029 Gabbay Mar 2007 A1
20070118151 Davidson May 2007 A1
20070250160 Rafiee Oct 2007 A1
20070255398 Yang et al. Nov 2007 A1
20070288089 Gurskis et al. Dec 2007 A1
20070293942 Mizraee Dec 2007 A1
20080015687 Lashinski et al. Jan 2008 A1
20080021537 Ben-Muvhar et al. Jan 2008 A1
20080065191 Bolduc et al. Mar 2008 A1
20080077234 Styrc Mar 2008 A1
20080125860 Webler et al. May 2008 A1
20080208328 Antocci et al. Aug 2008 A1
20080221672 Lamphere et al. Sep 2008 A1
20090005863 Goetz et al. Jan 2009 A1
20090062841 Amplatz et al. Mar 2009 A1
20090270966 Douk et al. Oct 2009 A1
20090270976 Douk et al. Oct 2009 A1
20090306768 Quadri Dec 2009 A1
20090319038 Gurskis et al. Dec 2009 A1
20100036479 Hill et al. Feb 2010 A1
20100082094 Quadri et al. Apr 2010 A1
20100100167 Bortlein et al. Apr 2010 A1
20100174363 Castro Jul 2010 A1
20100179648 Richter et al. Jul 2010 A1
20100179649 Richter et al. Jul 2010 A1
20100185275 Richter et al. Jul 2010 A1
20100249923 Alkhatib et al. Sep 2010 A1
20100262232 Annest Oct 2010 A1
20100280606 Naor Nov 2010 A1
20100298931 Quadri et al. Nov 2010 A1
20110112632 Chau et al. May 2011 A1
20110137397 Chau Jun 2011 A1
20110137409 Yang et al. Jun 2011 A1
20110172784 Richter et al. Jul 2011 A1
20110282438 Drews et al. Nov 2011 A1
20110313515 Quadri et al. Dec 2011 A1
20110319988 Schankereli et al. Dec 2011 A1
20110319989 Lane et al. Dec 2011 A1
20120022639 Hacohen Jan 2012 A1
20120059450 Chiang et al. Mar 2012 A1
20120078353 Quadri et al. Mar 2012 A1
20120078360 Rafiee Mar 2012 A1
20120179244 Schankereli et al. Jul 2012 A1
20120215303 Quadri et al. Aug 2012 A1
20120316642 Yu et al. Dec 2012 A1
20120323316 Chau et al. Dec 2012 A1
20140018906 Rafiee Jan 2014 A1
20140128965 Rafiee May 2014 A1
20140163668 Rafiee Jun 2014 A1
20140358223 Rafiee et al. Dec 2014 A1
20140039083 Rafiee Feb 2015 A1
Foreign Referenced Citations (7)
Number Date Country
2412397 Feb 2012 EP
100 718 Dec 2010 RU
WO2007121314 Oct 2007 WO
WO2012061809 May 2012 WO
WO2013131069 Sep 2013 WO
WO2015069947 May 2015 WO
WO2015148821 Oct 2015 WO
Non-Patent Literature Citations (6)
Entry
International Search Report, for related application No. PCT/US2011/059586, dated May 25, 2012.
International Preliminary Report on Patentability and Written Opinion, or related application No. PCT/US2011/059586, dated May 25, 2012.
BioIntegral Surgical, Mitral Valve Restoration System.
International Search Report for co-pending international application No. PCT/US2013/028774, dated Jun. 14, 2013.
International Preliminary Report on Patentability and Written Opinion, on related application No. PCT/US2014/064431 dated Mar. 26, 2015.
International Search Report, for related application No. PCT/US2015/022782, dated Jun. 18, 2015.
Related Publications (1)
Number Date Country
20170128206 A1 May 2017 US
Provisional Applications (1)
Number Date Country
61723734 Nov 2012 US
Continuation in Parts (1)
Number Date Country
Parent 14074517 Nov 2013 US
Child 15413017 US